The majority of the examined MSS-associated NFIX mutations did not act via the previously reported target genes, BBX or GFAP, and we therefore hypothesized that other downstream target genes may be involved in skeletal biology. The gene discussed is BBX; the disease is Marinesco-Sjogren syndrome.